Public research preview

Robert J. Wittman, Representative disclosure: Abbott Laboratories Common Stock (ABT)

Disclosed a buy transaction in Abbott Laboratories Common Stock (ABT). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Sandsynligvis for sent
24/100
Signalkvalitet
63/100
Datakvalitet
93%
Høj kvalitet

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
13 May 2022, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
24 days

Tidslinje

Transaktionsdato

19 Apr 2022

Offentliggørelse

13 May 2022

Nu

Sporet i dag

Indberetningsforsinkelse: 24 dage

Kursbevægelse

Komplet dækning

Udbyder
Yahoo Finance daily close
Hentet
10. jun. 2026

Kursforløb

ABT fra kontekst før transaktionen til seneste lukkekurs.

Købt

19. apr. 2022 · 110,89 USD · Endnu ikke offentlig

Systemets beslutning

Ville have købtStrategien ville have købt dette signal, men købsvinduet er lukket. Simuleret entry den 13. maj 2022 til 101,555 USD. Siden entry: -10,9 %. Planlagt exit den 13. jul. 2022 efter 40 handelsdage.

Vindue lukket82,6109,7136,8USDDato19. apr.13. maj8. jun.Officiel offentliggørelse13. majPlanlagt exit101,6SystemkøbKøbtOffentliggørelseSeneste
  • Endnu ikke offentlig
  • Købsvindue
  • Vindue lukket
  • Systemkøb
  • Planlagt exit
Observeret luk ved transaktion
110,89
Observeret luk ved offentliggørelse
101,555
Observeret seneste luk
90,5
Bevægelse før indberetning
-8,4 %
Bevægelse efter indberetning
-10,9 %
Markedsjusteret bevægelse
-10,9 %
1w since disclosure
+3,1 %
1m since disclosure
-3,6 %
3m since disclosure
+1,0 %
Topstigning før indberetning
+2,8 %
Tilbagetrækning fra top
-10,9 %

Why Copy Window is Probably too late

Supporting factors

  • Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $1,001 - $15,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 13 May 2022, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidebuy
value1001
sourcehouse_stock_act
tickerABT
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/20021015.pdf
personNameRobert J. Wittman
amountRange$1,001 - $15,000
companyNameAbbott Laboratories (ABT)
publishedAt2022-05-13T00:00:00.000Z
rawDocumentIdraw-us-house-20021015-0
disclosureDate2022-05-13
transactionDate2022-04-19
transactionTypeP